NCT04383210 2025-04-03Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid TumorsElevation OncologyPhase 2 Terminated54 enrolled 11 charts
NCT03241745 2024-12-27A Study of Nivolumab in Selected Uterine Cancer PatientsMemorial Sloan Kettering Cancer CenterPhase 2 Completed35 enrolled 8 charts
NCT04239443 2020-01-27Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and Uterine CancerHunan Cancer HospitalPhase 2 Unknown120 enrolled
NCT00414076 2018-11-20Letrozole Versus Observation in Patients With Newly Diagnosed Uterine LeiomyosarcomaM.D. Anderson Cancer CenterPhase 2 Terminated9 enrolled 7 charts
NCT00282087 2014-12-01Adjuvant Chemotherapy for High Risk Uterine LeiomyosarcomaSarcoma Alliance for Research through CollaborationPhase 2 Completed47 enrolled 16 charts
NCT00505492 2011-09-15Malignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/ChemotherapyM.D. Anderson Cancer CenterPhase 2 Terminated4 enrolled